These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 35363396)
1. NLGP regulates RGS5-TGFβ axis to promote pericyte-dependent vascular normalization during restricted tumor growth. Dasgupta S; Saha A; Ganguly N; Bhuniya A; Dhar S; Guha I; Ghosh T; Sarkar A; Ghosh S; Roy K; Das T; Banerjee S; Pal C; Baral R; Bose A FASEB J; 2022 May; 36(5):e22268. PubMed ID: 35363396 [TBL] [Abstract][Full Text] [Related]
2. RGS5-TGFβ-Smad2/3 axis switches pro- to anti-apoptotic signaling in tumor-residing pericytes, assisting tumor growth. Dasgupta S; Ghosh T; Dhar J; Bhuniya A; Nandi P; Das A; Saha A; Das J; Guha I; Banerjee S; Chakravarti M; Dasgupta PS; Alam N; Chakrabarti J; Majumdar S; Chakrabarti P; Storkus WJ; Baral R; Bose A Cell Death Differ; 2021 Nov; 28(11):3052-3076. PubMed ID: 34012071 [TBL] [Abstract][Full Text] [Related]
3. Normalization of tumor microenvironment by neem leaf glycoprotein potentiates effector T cell functions and therapeutically intervenes in the growth of mouse sarcoma. Barik S; Banerjee S; Mallick A; Goswami KK; Roy S; Bose A; Baral R PLoS One; 2013; 8(6):e66501. PubMed ID: 23785504 [TBL] [Abstract][Full Text] [Related]
4. Neem leaf glycoprotein prophylaxis transduces immune dependent stop signal for tumor angiogenic switch within tumor microenvironment. Banerjee S; Ghosh T; Barik S; Das A; Ghosh S; Bhuniya A; Bose A; Baral R PLoS One; 2014; 9(11):e110040. PubMed ID: 25391149 [TBL] [Abstract][Full Text] [Related]
5. Neem leaf glycoprotein is superior than cisplatin and sunitinib malate in restricting melanoma growth by normalization of tumor microenvironment. Barik S; Bhuniya A; Banerjee S; Das A; Sarkar M; Paul T; Ghosh T; Ghosh S; Roy S; Pal S; Bose A; Baral R Int Immunopharmacol; 2013 Sep; 17(1):42-9. PubMed ID: 23747315 [TBL] [Abstract][Full Text] [Related]
6. NLGP counterbalances the immunosuppressive effect of tumor-associated mesenchymal stem cells to restore effector T cell functions. Ghosh T; Nandi P; Ganguly N; Guha I; Bhuniya A; Ghosh S; Sarkar A; Saha A; Dasgupta S; Baral R; Bose A Stem Cell Res Ther; 2019 Sep; 10(1):296. PubMed ID: 31547863 [TBL] [Abstract][Full Text] [Related]
7. Transcription profiling of platelet-derived growth factor-B-deficient mouse embryos identifies RGS5 as a novel marker for pericytes and vascular smooth muscle cells. Bondjers C; Kalén M; Hellström M; Scheidl SJ; Abramsson A; Renner O; Lindahl P; Cho H; Kehrl J; Betsholtz C Am J Pathol; 2003 Mar; 162(3):721-9. PubMed ID: 12598306 [TBL] [Abstract][Full Text] [Related]
8. Neem Leaf Glycoprotein Disrupts Exhausted CD8+ T-Cell-Mediated Cancer Stem Cell Aggression. Chakravarti M; Bera S; Dhar S; Sarkar A; Choudhury PR; Ganguly N; Das J; Sultana J; Guha A; Biswas S; Das T; Hajra S; Banerjee S; Baral R; Bose A Mol Cancer Res; 2024 Aug; 22(8):759-778. PubMed ID: 38743057 [TBL] [Abstract][Full Text] [Related]
9. Regulator of G-protein signaling 5 regulates the shift from perivascular to parenchymal pericytes in the chronic phase after stroke. Roth M; Gaceb A; Enström A; Padel T; Genové G; Özen I; Paul G FASEB J; 2019 Aug; 33(8):8990-8998. PubMed ID: 31039042 [TBL] [Abstract][Full Text] [Related]
10. RGS5 expression is a quantitative measure of pericyte coverage of blood vessels. Mitchell TS; Bradley J; Robinson GS; Shima DT; Ng YS Angiogenesis; 2008; 11(2):141-51. PubMed ID: 18038251 [TBL] [Abstract][Full Text] [Related]
11. Age-Dependent RGS5 Loss in Pericytes Induces Cardiac Dysfunction and Fibrosis. Tamiato A; Tombor LS; Fischer A; Muhly-Reinholz M; Vanicek LR; Toğru BN; Neitz J; Glaser SF; Merten M; Rodriguez Morales D; Kwon J; Klatt S; Schumacher B; Günther S; Abplanalp WT; John D; Fleming I; Wettschureck N; Dimmeler S; Luxán G Circ Res; 2024 May; 134(10):1240-1255. PubMed ID: 38563133 [TBL] [Abstract][Full Text] [Related]
15. Combinational therapy of interferon-α and chemotherapy normalizes tumor vasculature by regulating pericytes including the novel marker RGS5 in melanoma. Liu P; Zhang C; Chen J; Zhang R; Ren J; Huang Y; Zhu F; Li Z; Wu G J Immunother; 2011 Apr; 34(3):320-6. PubMed ID: 21389866 [TBL] [Abstract][Full Text] [Related]
16. Immunotherapeutic targeting of established sarcoma in Swiss mice by tumor-derived antigen-pulsed NLGP matured dendritic cells is CD8+ T-cell dependent. Mallick A; Barik S; Ghosh S; Roy S; Sarkar K; Bose A; Baral R Immunotherapy; 2014; 6(7):821-31. PubMed ID: 25290415 [TBL] [Abstract][Full Text] [Related]
17. The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study. Das J; Bera S; Ganguly N; Guha I; Ghosh Halder T; Bhuniya A; Nandi P; Chakravarti M; Dhar S; Sarkar A; Das T; Banerjee S; Ghose S; Bose A; Baral R Front Immunol; 2024; 15():1325161. PubMed ID: 38585261 [TBL] [Abstract][Full Text] [Related]
18. Listeria-based vaccination against the pericyte antigen RGS5 elicits anti-vascular effects and colon cancer protection. Anderson TS; McCormick AL; Daugherity EA; Oladejo M; Okpalanwaka IF; Smith SL; Appiah D; Wood LM; Lowe DB Oncoimmunology; 2023; 12(1):2260620. PubMed ID: 37781234 [TBL] [Abstract][Full Text] [Related]
19. Coexpression of Notch3 and Rgs5 in the pericyte-vascular smooth muscle cell axis in response to pulp injury. Lovschall H; Mitsiadis TA; Poulsen K; Jensen KH; Kjeldsen AL Int J Dev Biol; 2007; 51(8):715-21. PubMed ID: 17939118 [TBL] [Abstract][Full Text] [Related]
20. Neem leaf glycoprotein activates CD8(+) T cells to promote therapeutic anti-tumor immunity inhibiting the growth of mouse sarcoma. Mallick A; Barik S; Goswami KK; Banerjee S; Ghosh S; Sarkar K; Bose A; Baral R PLoS One; 2013; 8(1):e47434. PubMed ID: 23326300 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]